200 related articles for article (PubMed ID: 448074)
1. Action of the C3b-inactivator on the cell-bound C3b.
Law SK; Fearon DT; Levine RP
J Immunol; 1979 Mar; 122(3):759-65. PubMed ID: 448074
[TBL] [Abstract][Full Text] [Related]
2. Complement receptor binding of C3b-coated cells treated with C3b inactivator, beta 1H globulin and trypsin.
Carlo JR; Ruddy S; Studer EJ; Conrad DH
J Immunol; 1979 Aug; 123(2):523-8. PubMed ID: 88474
[TBL] [Abstract][Full Text] [Related]
3. Qualitative and quantitative assessment of C3-receptor reactivities on lymphoid and phagocytic cells.
Schmitt M; Mussel HH; Dierich MP
J Immunol; 1981 May; 126(5):2042-7. PubMed ID: 7217681
[TBL] [Abstract][Full Text] [Related]
4. Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules.
Medicus RG; Melamed J; Arnaout MA
Eur J Immunol; 1983 Jun; 13(6):465-70. PubMed ID: 6222909
[TBL] [Abstract][Full Text] [Related]
5. Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.
Pangburn MK; Schreiber RD; Müller-Eberhard HJ
J Exp Med; 1977 Jul; 146(1):257-70. PubMed ID: 301546
[TBL] [Abstract][Full Text] [Related]
6. Cleavage of C4b by C3b inactivator: production of a nicked form of C4b, C4b', as an intermediate cleavage product of C4b by C3b inactivator.
Nagasawa S; Ichihara C; Stroud RM
J Immunol; 1980 Aug; 125(2):578-82. PubMed ID: 7391570
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of K-76 monocarboxylic acid, an anticomplementary agent, on the C3b inactivator system.
Hong K; Kinoshita T; Kitajima H; Inoue K
J Immunol; 1981 Jul; 127(1):104-8. PubMed ID: 7240739
[TBL] [Abstract][Full Text] [Related]
8. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.
Davis AE; Harrison RA; Lachmann PJ
J Immunol; 1984 Apr; 132(4):1960-6. PubMed ID: 6607952
[TBL] [Abstract][Full Text] [Related]
9. Relative importance of C3b inactivator and beta 1H globulin in the modulation of the properdin amplification loop in systemic lupus erythematosus.
Whaley K; Schur PH; Ruddy S
Clin Exp Immunol; 1979 Jun; 36(3):408-14. PubMed ID: 114347
[TBL] [Abstract][Full Text] [Related]
10. Mouse C3b/C4b inactivator: purification and properties.
Kai S; Fujita T; Gigli I; Nussenzweig V
J Immunol; 1980 Dec; 125(6):2409-15. PubMed ID: 6776193
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
12. Third component of complement (C3): structural properties in relation to functions.
Bokisch VA; Dierich MP; Mūller-Eberhard HJ
Proc Natl Acad Sci U S A; 1975 Jun; 72(6):1989-93. PubMed ID: 1056006
[TBL] [Abstract][Full Text] [Related]
13. C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.
Whaley K; Schur PH; Ruddy S
J Clin Invest; 1976 Jun; 57(6):1554-63. PubMed ID: 819459
[TBL] [Abstract][Full Text] [Related]
14. Purification of the human complement control protein C3b inactivator.
Crossley LG; Porter RR
Biochem J; 1980 Oct; 191(1):173-82. PubMed ID: 6451220
[TBL] [Abstract][Full Text] [Related]
15. Demonstration of the complement regulating protein, beta 1H, in skin biopsies from patients with bullous pemphigoid.
Carlo JR; Gammon WR; Sams WM; Ruddy S
J Invest Dermatol; 1979 Dec; 73(6):551-3. PubMed ID: 390060
[TBL] [Abstract][Full Text] [Related]
16. Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c.
Laursen SB; Thiel S; Teisner B; Holmskov U; Wang Y; Sim RB; Jensenius JC
Immunology; 1994 Apr; 81(4):648-54. PubMed ID: 7518801
[TBL] [Abstract][Full Text] [Related]
17. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes.
Medof ME; Iida K; Mold C; Nussenzweig V
J Exp Med; 1982 Dec; 156(6):1739-54. PubMed ID: 7175439
[TBL] [Abstract][Full Text] [Related]
18. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.
Ross GD; Newman SL; Lambris JD; Devery-Pocius JE; Cain JA; Lachmann PJ
J Exp Med; 1983 Aug; 158(2):334-52. PubMed ID: 6224880
[TBL] [Abstract][Full Text] [Related]
19. Receptor-binding sites on C3 and C3b.
Dierich MP; Bokisch VA
J Immunol; 1977 Jun; 118(6):2145-50. PubMed ID: 864256
[TBL] [Abstract][Full Text] [Related]
20. A molecular basis of activation of the alternative pathway of human complement.
Austen KF; Fearon DT
Adv Exp Med Biol; 1979; 120B():3-17. PubMed ID: 390986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]